A Prospective Observational Survey on the Long-Term Effect of LDL Apheresis on Drug-Resistant Nephrotic Syndrome

BACKGROUND/AIMS: LDL apheresis (LDL-A) is used for drug-resistant nephrotic syndrome (NS) as an alternative therapy to induce remission by improvement of hyperlipidemia. Several clinical studies have suggested the efficacy of LDL-A for refractory NS, but the level of evidence remains insufficient. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Muso, Eri, Mune, Masatoshi, Hirano, Tsutomu, Hattori, Motoshi, Kimura, Kenjiro, Watanabe, Tsuyoshi, Yokoyama, Hitoshi, Sato, Hiroshi, Uchida, Shunya, Wada, Takashi, Shoji, Tetsuo, Takemura, Tsukasa, Yuzawa, Yukio, Ogahara, Satoru, Sugiyama, Satoshi, Iino, Yasuhiko, Sakai, Soichi, Ogura, Yousuke, Yukawa, Susumu, Nishizawa, Yoshiki, Yorioka, Noriaki, Imai, Enyu, Matsuo, Seiichi, Saito, Takao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592509/
https://www.ncbi.nlm.nih.gov/pubmed/26557843
http://dx.doi.org/10.1159/000437338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592509/
https://www.ncbi.nlm.nih.gov/pubmed/26557843
http://dx.doi.org/10.1159/000437338

Ejemplares similares